We have detected that your browser blocked our video player. Please enable popups and try again. Thank you. Consultative Forum on the Affordable Medicines Facility-Malaria (AMFm) 9/26/2008 Resources For the Future, Washington, D.C.     Add to My Saved Links Email this Webcast RSS Feeds Podcast Feeds Share Del.icio.us Digg Facebook Google Bookmarks Myspace Reddit     Additional Resources GlobalHealthFacts: Malaria Weekly TB/Malaria Reports on Malaria Affordable Medicines Facility-Malaria (AMFm) is the operational version of the "global subsidy" for malaria drugs first proposed in 2004 by an Institute of Medicine Committee. The purpose of AMFm is to provide widespread financial access to artemisinin-combination therapies (ACTs) and delay the emergence of resistance to artemisinins.   The purpose of this forum is to discuss the rationale for AMFm, and to explore biomedical, economic and operational challenges related to AMFm. Full version: Video Transcript Speakers for this session:   Welcome and Introduction Phil Sharp President Resources for the Future Introduction from the Chair Barry Bloom, Ph.D. Dean Harvard School of Public Health     Session 1: The Development and Future Impact of AMFm Challenge to Concept: The Global Subsidy for ACTs Kenneth Arrow, Ph.D., M.A. Professor of Economics Stanford University Sir Richard Peto Professor of Medical Statistics and Epidemiology Oxford University Concept to Reality: AMFm Julian Schweitzer Director for Human Development in the South Asia Region The World Bank The Catalyst: Roll Back Malaria Partnership Awa Marie Coll-Seck Executive Secretary Roll Back Malaria Partnership Session 2: Support for AMFm Full version: Video Transcript Speakers for this session:   View from the Malaria-Endemic World Eyitayo Lambo Former Minister of Health Nigeria     The Global Fund: Possible Implementer of AMFm Jean-Paul Moatti, Ph.D. Senior Advisor Global Fund to Fight AIDS, Tuberculosis and Malaria     A Donor Country Perspective Delna Ghandhi Department for International Development United Kingdom     Discussion     Morning Wrap-Up Session 3: The World With and Without AMFm: Issues to Consider Full version: Video Transcript Speakers for this session:   Resistance to Malaria Drugs Christopher Plowe, M.D., M.P.H. Professor of Medicine, University of Maryland School of Medicine Chief, Center for Vaccine Development     Artemisinin Use by Pregnant Women Nicholas White, D.Sc. Fellow Royal Society     Use of Diagnostic Technologies for Malaria Christopher Whitty, Ph.D. Professor of International Health London School of Hygiene & Tropical Medicine     Pilot Experiences to Inform AMFm Oliver Sabot Director of Malaria Control Team Clinton Foundation     Reaching the Poorest of the Poor with Effective Malaria Drugs Ricardo Bitrán, Ph.D. Bitrán and Associates     Discussion and Wrap-Up Barry Bloom Dean Harvard School of Public Health EMAIL ALERTS Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.   FAQs How to disable a pop-up blocker How to view a webcast How to listen to a podcast More...   CONTACT US Contact us by email with any comments, problems, suggestions. Call the kaisernetwork.org Help Desk at 202-347-5270. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... About Us     Privacy Policy      Help      Site Map